These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 30675738)
1. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma. Choi WR; Oh JS; Roh JL; Kim JS; Oh I; Choi SH; Nam SY; Kim SY Head Neck; 2019 Jun; 41(6):1846-1853. PubMed ID: 30675738 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma. Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas. Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment quantitative Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429 [TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812 [TBL] [Abstract][Full Text] [Related]
10. Prediction of distant metastasis and survival in adenoid cystic carcinoma using quantitative Lim WS; Oh JS; Roh JL; Kim JS; Kim SJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2018 Feb; 77():98-104. PubMed ID: 29362133 [TBL] [Abstract][Full Text] [Related]
11. Use of Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718 [No Abstract] [Full Text] [Related]
12. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649 [TBL] [Abstract][Full Text] [Related]
14. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y; Lu P; Yu L Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968 [TBL] [Abstract][Full Text] [Related]
15. Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma. Almuhaimid TM; Lim WS; Roh JL; Oh JS; Kim JS; Kim SJ; Choi SH; Nam SY; Kim SY J Cancer Res Clin Oncol; 2018 Dec; 144(12):2485-2493. PubMed ID: 30293119 [TBL] [Abstract][Full Text] [Related]
16. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma. Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816 [TBL] [Abstract][Full Text] [Related]
17. Hypoxic volume evaluated by Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021 [TBL] [Abstract][Full Text] [Related]
18. Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery. Vargas HA; Burger IA; Goldman DA; Miccò M; Sosa RE; Weber W; Chi DS; Hricak H; Sala E Eur Radiol; 2015 Nov; 25(11):3348-53. PubMed ID: 25916387 [TBL] [Abstract][Full Text] [Related]
19. Volumetric parameters on Liu G; Hu Y; Cheng X; Wang Y; Gu Y; Liu T; Shi H BMC Cancer; 2019 Aug; 19(1):790. PubMed ID: 31395059 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of Li Y; Li Y; Huang Y; Wu X; Yang Z; Wu C; Jiang L Ann Nucl Med; 2021 Sep; 35(9):1048-1057. PubMed ID: 34101153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]